Science
Tool could improve success in translating drugs from animal studies to humans – Medical Xpress
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
Scientists might be able to catch problems like this one earlier in the drug development process, when drugs move from testing in animals to clinical trials, with a new computational model developed by researchers from Purdue University and Massachusetts Institute of Technology.
The researchers call the model “TransComp-R.” In a study publi…
-
Noosa News24 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News23 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General17 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business17 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?